
Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowThe chart is not accessible to screen readers. Please switch to the table view to access the data.
In 2023, the largest amount of corporate facility investments within the South Korean biotech industry was allocated to the biopharmaceutical sector, amounting to around *** trillion South Korean won. This was followed by the biochemical and bioenergy sector at about *** trillion won. Investments into facilities that year decreased across all sectors other than biopharmaceuticals, where growth was under *** percent.
Log in or register to access precise data.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
About the industry
About the region
Selected statistics
Other regions
Related statistics
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.